4//SEC Filing
BOLGER JOHN C 4
Accession 0001209191-21-054292
CIK 0001674930other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 5:50 PM ET
Size
19.8 KB
Accession
0001209191-21-054292
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-30$3.92/sh+312$1,225→ 2,312 total - Sale
Common Stock
2021-08-30$91.38/sh−312$28,511→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-30−312→ 938 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (312 underlying)
Footnotes (3)
- [F1]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F3]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001183863
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 5:50 PM ET
- Size
- 19.8 KB